Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-021834
Filing Date
2025-05-02
Accepted
2025-05-02 16:10:22
Documents
95
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 1Q25 FORM 10-Q (3.31.25) mrk-20250331.htm   iXBRL 10-Q 2001985
2 EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO exhibit311-rule13ax14a15dx.htm EX-31.1 8388
3 EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO exhibit312-rule13ax14a15dx.htm EX-31.2 8234
4 EX-32.1 SECTION 1350 CERTIFICATION OF CEO exhibit321-section1350cert.htm EX-32.1 3867
5 EX-32.2 SECTION 1350 CERTIFICATION OF CFO exhibit322-section1350cert.htm EX-32.2 3715
  Complete submission text file 0001628280-25-021834.txt   12135619

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20250331.xsd EX-101.SCH 65998
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrk-20250331_cal.xml EX-101.CAL 82974
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20250331_def.xml EX-101.DEF 445714
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20250331_lab.xml EX-101.LAB 768383
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20250331_pre.xml EX-101.PRE 645289
97 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20250331_htm.xml XML 2562237
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 25908550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)